Patent Law Alert:SUPREME COURT CLARIFIES THE RULES FOR BIOSIMILARS

(June 12, 2017)  In Sandoz v. Amgen, 582 U. S. ___ (2017), the Supreme Court addressed the “plain language” of a “carefully crafted and detailed enforcement scheme” relating to “biologic” drugs. Under this complex statute that was enacted as part of ObamaCare as an effort to get generic biosimilar and interchangeable biologic drugs on the market quicker […]

In The Press:IPWatchdog Turns to Partner Charles R. Macedo for Insight on SCOTUS Decision Declaring Disparagement Clause of Lanham Act Unconstitutional in Matal v. Tam

Industry Reaction to SCOTUS First Amendment Decision in Matal v. Tam – IPWatchdog.com | Patents & Patent Law  By Gene Quinn   Charles MacedoPartner, Amster, Rothstein & Ebenstein LLP Today, the U.S. Supreme Court found that the Lanham Act provision prohibiting the federal registration of trademarks that “may disparage . . . persons, living or […]